Defence Science and Technology Laboratory
New test for sepsis could improve survival rates thanks to Dstl scientists
A new test for sepsis is now available for commercial licence.
A new test for sepsis, which globally claims 6 million lives a year, could soon be available thanks to an innovation by scientists at the Defence Science and Technology Laboratory (Dstl).
The ground-breaking innovation will mean that patients with sepsis stand a much better chance of survival as diagnosis and treatment can take place before symptoms even appear.
For patients that have contracted sepsis, every treatment hour is crucial as survival rates can drop by up to 8% per hour, and if detected and treated early enough there is a significant increase in recovery and survival rates. However, the current bacterial diagnosis method needs the patient to show symptoms of having sepsis by which time the condition is already well advanced. It then additionally takes a number of hours and possibly days for test results to come back during which time the patient’s condition will have deteriorated further.
The new Dstl innovation can detect sepsis before symptoms appear and provides fast and accurate results to give medical teams hours or even days of critical extra time to treat this life-threatening condition.
Minister for Defence Procurement Stuart Andrew said:
This crucial breakthrough in sepsis treatment is an outstanding example of the pioneering research carried out by Dstl scientists and highlights how lessons learned on the battlefield can have a huge impact on improving the day-to-day lives of UK citizens.
We continue to see how strong investment in defence results in knock-on benefits across a huge range of areas from revolutionary medicine to advanced mechanics.
It uses ‘biomarkers’, or predictors, that sepsis is present and has been demonstrated to be 97% accurate, following a decade-long study of 4,385 surgery patients in Germany and the UK.
Dr Roman Lukaszewski, the lead Dstl scientist behind the innovation, said:
This breakthrough comes from many years of work in this area to help Service personnel survive injury and infection on the front line. By detecting sepsis earlier, the therapeutic window is extended, treatments are more effective, and survivability rates are potentially increased.
In order to make this innovation available, Dstl has turned to its commercialisation organisation, Ploughshare Innovations, which is currently looking for a licensee to turn the invention into a product.
Dr Mark Gostock, from Ploughshare Innovations and responsible for getting this innovation into industry commented:
This innovation is a step-change in the pre-determination of sepsis and could potentially help millions of people worldwide. We are keen to see it put to good use and are actively seeking partners to turn it into a product to allow earlier treatment of sepsis which in turn, improves survivability and reduces treatment costs.
Sepsis affects around 30 million people each year worldwide and is increasing at a rate of 8 – 13% each year. In the UK, it incurs costs of around £15 billion and is responsible for more deaths than bowel, breast and prostate cancer combined.
For more information on the licensing opportunities for this invention, please visit the Ploughshare site.
Latest News from
Defence Science and Technology Laboratory
US and UK research labs collaborate on autonomy and AI19/10/2021 12:10:00
Integrated artificial intelligence technologies to support the armed forces are being developed as part of an international partnership agreement.
Dstl showcases autonomous future for army logistics07/10/2021 15:10:00
Uncrewed ground vehicles are being trialled for potential use in future resupply operations.
Global AI experts to present at Dstl’s virtual AI Fest05/10/2021 12:10:00
Attendees will explore the transformational impact of artificial intelligence (AI) on defence and security and discuss the topic of 'trustworthy AI'.
Diversity on the virtual battlefield01/10/2021 11:20:00
Dstl has been working with Slitherine Software and Battlefront to create a product with the same combat challenges – but with an important difference.
£3.8 million in contracts awarded to mitigate the radar risk of windfarms28/09/2021 13:10:00
Seven projects have been awarded funding to develop technologies that support the coexistence of offshore windfarms and UK air defence systems
Dstl trials innovative solutions to ‘wet gap’ military challenge22/09/2021 09:25:00
Industry works with defence to create amphibious vehicles, robots and drones in Map the Gap competition.
Portsmouth to host military event for MOD21/09/2021 09:15:00
Portsmouth has been selected to host a unique military training event to test the latest technology for military personnel.
Uncrewed marine platform to deliver next-generation coastal security17/09/2021 09:05:00
A new uncrewed marine platform with intelligent autonomy is now available for use by intelligence gathering and threat detection communities around the globe.